INS and polycystic ovary syndrome: In women with PCOS, the administration of metformin, a drug that increases insulin sensitivity, increases IGFBP-1 levels, reducing the IGF-1/IGFBP-1 ratio and thereby decreasing IGF-1 availability in peripheral tissues.